As shown in Figure 4, miR-145 negatively regulates FSCN1 mRNA levels in many different human cancers, including nasopharyngeal, laryngeal, esophageal, breast, lung, stomach, liver, colon, bladder, cervix, prostate, and cartilage cancers.72 This evidence concerns the gene FSCN1 and cancer.